Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

VHL Mouse anti-Human, Unlabeled, Clone: S2-647, BD

Mouse Monoclonal Antibody

Manufacturer:  BD Biosciences 564183

Catalog No. BDB564183


Add to cart

Description

Description

The S2-647 monoclonal antibody recognizes the Von Hippel-Lindau (VHL) protein. The VHL protein is expressed within the cytosol and nuclei of cells from a variety of tissues. It serves as a tumor suppressor and transcriptional repressor that is highly conserved from Drosophila to mammalian species. VHL binds to Elongin B and C subunits and other proteins as part of a E3 ubiquitin ligase complex that targets a variety of proteins, including HIF-1 alpha and Beta-2 adrenergic receptors, for proteasomal degradation. Aberrant VHL expression is associated with a number of diseases including Von Hippel-Lindau disease, a familial cancer syndrome, that predisposes individuals to hemangioblastomas of the central nervous system and retina, pheochromocytoma and renal cell carcinoma. Three distinct VHL isoforms ranging in molecular weight from approximately 19-30 kDa have been described.

Specifications

Specifications

VHL
S2-647
Unconjugated
Aqueous buffered solution containing ≤0.09% sodium azide.
Murine
IgG2b, κ
RUO
Primary
Human
Flow Cytometry
0.5mg/mL
VHL1; pVHL; Elongin binding protein; Protein G7; HRCA1; RCA1
Affinity Purified
Human VHL Recombinant Protein
0.1mg
Store undiluted at 4°C
Monoclonal
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit